Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-25

Clinical Trial Update: Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hypertonic saline solution to prevent acute kidney injury after heart transplantation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypertonic saline solution (Hypertonic saline)

Snippet

Sponsor: Fernando Bacal | Conditions: Heart Transplantation, Acute Kidney Injury | Phase 2 | Status: RECRUITING